glp-1 receptor Frontiers PDB-101: Molecule of the Month:

Fig.2 Pleiotropic effects of GLP1-RA leading to improvement MASLD/MASH [2] GLP-1RA in MASH Treatment: Clinical Progress Several GLP-1RAs and related agents are currently in various phases of clinical development for MASH treatment [4]

Accessed June 2, 2026.

British J

In the mid 1980s, John Eng was studying bioactive peptides from the venom of the Gila monster by screening for molecules with an amino-terminal histidine which he noted was shared by GLP-1 and other gut peptides

Whilst human studies demonstrating an impact on cognitive decline are still lacking, the current evidence points towards these drugs having a preventative effect, rather than in patients with established cognitive impairment

One of the limitations in this study was that blood glucose and eGFR levels were not adjusted for, while poor glycemic control and kidney dysfunction were found to be associated with increased risk of AF in patients with type 2 diabetes